Compliance and tolerability evaluation of diacerein versus s-adenosyl methionine in osteoarthritis patients

Journal Title: International Archives of Integrated Medicine - Year 2017, Vol 4, Issue 11

Abstract

Background: Diacerein and S-adenosyl methionine (SAMe) are symptomatic slow-acting drugs in osteoarthritis (SYSADOA). Diacerein is a semisynthetic, anthraquinone derivative, an interleukin 1beta inhibitor with anti-inflammatory, anti-catabolic and pro-anabolic properties on cartilage and synovial membrane. SAMe is a dietary supplement used in the management of OA. The objective of this study is to find out compliance and tolerability evaluation of Diacerein versus S-adenosyl methionine inpatients suffering from Osteoarthritis. Materials and methods: This was a prospective, randomized, interventional study conducted in Orthopedic OPD and ward in Rajah Muthiah Medical College and Hospital for a period of one year. A total of 80 patients were enrolled in this study as per the inclusion criteria. 40 patients in each group were randomly assigned to receive either diacerein 50mg BD or SAMe 200 mg TDS for12 weeks. The NSAID diclofenac 50 mg BD was administered orally for a short course of one week to both the groups to relieve acute symptoms. Efficacy of both the drugs was assessed using Lysholm knee scoring scale. The tolerability profile was evaluated during each clinical visit on weeks 1, 4 and 12. Results: Diacerein and SAMe which were symptomatic slow-acting drugs show a profound reduction in pain starting from 4th to 12th week of treatment. Lower GI side effects like diarrheawere observed in the diacerein group and insomnia was reported in the SAMe group. Though the overall adverse effects were more in the diacerein group, compliance was better with regard to drug intake Conclusion: Both diacerein and SAMe were found to be effective in reducing the pain in Osteoarthritis patients. Diacerein with a good compliance factor was less tolerable because of the incidence of diarrhea. SAMe though better tolerated has a compliance score of fair to good.

Authors and Affiliations

Gayathri C. R. , Vanitha Samuel, Senthilnathan A, Nirmala P

Keywords

Related Articles

Oral health status of 6-12 year old children attending a Government Hospital in Kashmir

Background: Dental caries is an irreversible disease, with a likelihood of new lesions that continue to affect humanity Dental caries or tooth decay is an acquired chronic infective disease process caused by the acidic b...

Study of post-prandial hypertriglyceridemia as an independent risk factor for ischemic heart disease in Government Dharmapuri Medical College, Dharmapuri

Introduction: Coronary heart disease is the leading cause of death in Western countries and it is now an increasing problem in developing countries too, due to changes in life style and dietary habits. Heart Disease is r...

Efficacy of Mifepristone and Misoprostol combination in termination of early pregnancy

Background: Unplanned and unwanted pregnancies are common occurrences in all societies, regardless of the level of medical, economic, educational or religious development present within them. Despite wider availability o...

Computerized tomography guided percutaneous transthoracic fine needle aspiration of lung lesions

Introduction: Computed tomogram guided fine needle aspiration cytology (FNAC) is an important and useful investigation to differentiate between benign and malignant lesions of lungs. With computed tomography (CT) it is...

Unusual site of presentation of W. Bancrofti with various forms of filaria seen on cytology smears - Report of 2 cases

Filariasis is a major public health problem in tropical countries like India, China, Indonesia, Africa and the Far East. Aspiration cytology often helps in demonstration of microfilaria and its various forms, from uncomm...

Download PDF file
  • EP ID EP411557
  • DOI -
  • Views 116
  • Downloads 0

How To Cite

Gayathri C. R. , Vanitha Samuel, Senthilnathan A, Nirmala P (2017). Compliance and tolerability evaluation of diacerein versus s-adenosyl methionine in osteoarthritis patients. International Archives of Integrated Medicine, 4(11), 6-13. https://europub.co.uk./articles/-A-411557